Percutaneous liquid ablation agent for tumor treatment and drug delivery
Science Translational Medicine | February 10, 2021 | Volume: 13 | Issue: 580 | Pages: No page available
10.1126/scitranslmed.abe3889
| PMID 33568519
An ionic liquid formulation ablates tumors, uniformly distributes drugs in the ablation zone, and has synergistic effects with chemotherapy.